Insider · CIK 0001255767
Radka Milanova
Files at BIXT (BIOXYTRAN, INC). First filing -, latest -.
In brief
Radka Milanova files SEC Form 4 as director at BIXT (BIOXYTRAN, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Radka Milanova has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +10,417 | $0.49 | $5,052 | 165,100 | Nov 18, 2025 |
| Nov 14, 2025 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +38,588 | $0.35 | $14k | 203,688 | Nov 18, 2025 |
| Jan 6, 2025 | BIXT BIOXYTRAN, INC | AGrant or award Preferred | +97,535 | $0.32 | $31k | 154,683 | Jan 14, 2025 |
| Oct 25, 2024 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +20,619 | $0.46 | $9,485 | 57,148 | Oct 28, 2024 |
Questions about Radka Milanova
Answered from the filings on this page, as of the latest one.
Is Radka Milanova buying or selling?
Radka Milanova has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Radka Milanova's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Radka Milanova has 0.
Where does Radka Milanova file Form 4?
Radka Milanova has filed Form 4 at BIXT (BIOXYTRAN, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.